Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Hemodialysis-associated Thromboinflammation

NCT07206524 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Hemodialysis
Thromboinflammation
Hemodialysis Complication
End Stage Renal Disease (ESRD)

Interventions

OTHER: Hemodialysis using dialysate containing citric acid and magnesium at a concentration of 1.0 mmol/L
OTHER: Hemodialysis using acetic acid dialysate with magnesium 0.5 mmol/L
OTHER: Hemodialysis using citric acid dialysate with magnesium 0.75 mmol/L

Sponsor

Universitair Ziekenhuis Brussel

Collaborators

[object Object]
[object Object]